Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML. (Q47755956)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML. |
scientific article |
Statements
1 reference
Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML. (English)
1 reference
1 reference
1 reference
1 reference
Michelle Maria Araujo Cruz
1 reference
Nidhi Jyotsana
1 reference
Amit Sharma
1 reference
Haiyang Yun
1 reference
Kerstin Görlich
1 reference
Martin Wichmann
1 reference
Adrian Schwarzer
1 reference
Felicitas Thol
1 reference
Johann Meyer
1 reference
Reinhard Haemmerle
1 reference
Eduard A Struys
1 reference
Erwin E Jansen
1 reference
Ute Modlich
1 reference
Zhixiong Li
1 reference
Robert Geffers
1 reference
Robert Lindner
1 reference
Ulrich Lehmann
1 reference
Jürgen Krauter
1 reference
Arnold Ganser
1 reference
Michael Heuser
1 reference
16 August 2013
1 reference
1 reference
122
1 reference
16
1 reference
2877-2887
1 reference
Identifiers
1 reference
1 reference